183 related articles for article (PubMed ID: 31610910)
1. The impact of the immunotherapy revolution on lymph nodal surgery.
Eggermont AMM
Bull Cancer; 2020 Jun; 107(6):640-641. PubMed ID: 31610910
[No Abstract] [Full Text] [Related]
2. Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage III melanoma.
Schermers B; Franke V; Rozeman EA; van de Wiel BA; Bruining A; Wouters MW; van Houdt WJ; Ten Haken B; Muller SH; Bierman C; Ruers TJM; Blank CU; van Akkooi ACJ
Br J Surg; 2019 Apr; 106(5):519-522. PubMed ID: 30882901
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant in Situ and Systemic Immunotherapy with Lymph Node Cryoablation in Resectable Stage III Melanoma Metastasis: a Proof-of-Concept Study.
Braud A; Auloge P; Meyer N; Bouvrais C; Gharbi M; Lang H; Gangi A; Lipsker D
Cardiovasc Intervent Radiol; 2024 May; 47(5):567-572. PubMed ID: 38570342
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Therapy of Melanoma.
Tarhini AA
Hematol Oncol Clin North Am; 2021 Feb; 35(1):73-84. PubMed ID: 33759774
[TBL] [Abstract][Full Text] [Related]
6. Treatment of High Risk Resected Melanoma in Australia: Current Landscape and Practises.
Bhave P; Haydon A
Australas J Dermatol; 2020 Aug; 61(3):203-209. PubMed ID: 32403192
[TBL] [Abstract][Full Text] [Related]
7. The sentinel node biopsy has come of age.
McGregor JM
Br J Dermatol; 2019 Aug; 181(2):423. PubMed ID: 30724352
[No Abstract] [Full Text] [Related]
8. [Stage III melanoma: Sentinel node biopsy, completion lymph node dissection and prospects of adjuvant therapy. A French national survey on current and envisaged practices].
Orion C; Dinulescu M; Dalac-Rat S; Giacchero D; Jouary T; Lebbé C; Leccia MT; Maubec E; Meyer N; Mortier L; Dupuy A;
Ann Dermatol Venereol; 2020 Jan; 147(1):9-17. PubMed ID: 31761496
[TBL] [Abstract][Full Text] [Related]
9. Completion Node Dissection After Sentinel Node Biopsy in Melanoma.
Delman KA; Wong SL
JAMA Surg; 2018 Nov; 153(11):1045-1046. PubMed ID: 30027279
[No Abstract] [Full Text] [Related]
10. Third-line pembrolizumab-induced immune-related interstitial pneumonitis after ipilimumab and nivolumab failure.
Oya K; Nakamura Y; Fujisawa Y; Endo R; Tanaka R; Ishitsuka Y; Maruyama H; Watanabe R; Okiyama N; Fujimoto M
Eur J Dermatol; 2018 Feb; 28(1):129-130. PubMed ID: 29400284
[No Abstract] [Full Text] [Related]
11. Uncertainties in the management of melanoma nodal metastasis.
Zoras O; Lasithiotakis K; Balch CM
Eur J Surg Oncol; 2015 Jul; 41(7):811-3. PubMed ID: 25980747
[No Abstract] [Full Text] [Related]
12. The extent of surgery for stage III melanoma: how much is appropriate?
Franke V; van Akkooi ACJ
Lancet Oncol; 2019 Mar; 20(3):e167-e174. PubMed ID: 30842060
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
Pelster MS; Amaria RN
Curr Treat Options Oncol; 2020 Feb; 21(2):10. PubMed ID: 32025932
[TBL] [Abstract][Full Text] [Related]
14. Treatment of a patient with HIV and metastatic melanoma with consequitive ipilimumab and nivolumab.
Tomsitz D; Hein R; Biedermann T; Kohlmeyer J
J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):e26-e28. PubMed ID: 28662283
[No Abstract] [Full Text] [Related]
15. A glimpse of future management of melanoma.
Cochran AJ
Arch Dermatol; 2009 Oct; 145(10):1176-7. PubMed ID: 19841407
[No Abstract] [Full Text] [Related]
16. Novel therapies for unresectable and metastatic melanoma.
Karimkhani C; Reddy BY; Dellavalle RP; Sundararajan S
BMJ; 2017 Nov; 359():j5174. PubMed ID: 29191943
[No Abstract] [Full Text] [Related]
17. [To outwit melanoma with its own tricks].
Bischoff A
MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
[No Abstract] [Full Text] [Related]
18. Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma.
Kreft S; Gesierich A; Eigentler T; Franklin C; Valpione S; Ugurel S; Utikal J; Haferkamp S; Blank C; Larkin J; Garbe C; Schadendorf D; Lorigan P; Schilling B
Eur J Cancer; 2019 Jul; 116():207-215. PubMed ID: 31212163
[TBL] [Abstract][Full Text] [Related]
19. Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma.
Reijers ILM; Rawson RV; Colebatch AJ; Rozeman EA; Menzies AM; van Akkooi ACJ; Shannon KF; Wouters MW; Saw RPM; van Houdt WJ; Zuur CL; Nieweg OE; Ch'ng S; Klop WMC; Spillane AJ; Long GV; Scolyer RA; van de Wiel BA; Blank CU
JAMA Surg; 2022 Apr; 157(4):335-342. PubMed ID: 35138335
[TBL] [Abstract][Full Text] [Related]
20. [Advances in immunotherapy for metastatic melanoma].
Oláh J
Magy Onkol; 2017 Jun; 61(2):132-136. PubMed ID: 28585614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
